A Novel Targeted Therapeutic Agent to Pancreatic Cancer

被引：0
|
作者：
Senadhi, Viplove [1 ]
Kayarthodi, Shubha [2 ]
Fujimura, Yasuo [2 ]
Ghanapathy, Bhat [2 ]
Buchsbaum, D. [3 ]
Rao, Veena [2 ]
Reddy, E. Shyam P. [2 ]
机构：
[1] Johns Hopkins Univ, Dept Internal Med, Baltimore, MD USA
[2] Morehouse Sch Med, Canc Biol Program, Dept OB GYN, Atlanta, GA 30310 USA
[3] Univ Alabama, Dept Radiol, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2009年 / 104卷
关键词：
D O I：
10.14309/00000434-200910003-00220
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
220
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [21] Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer
    Sawahara, H.
    Shiraha, H.
    Uchida, D.
    Kato, H.
    Nagahara, T.
    Iwamuro, M.
    Kataoka, J.
    Horiguchi, S.
    Watanabe, M.
    Sakaguchi, M.
    Takaki, A.
    Nouso, K.
    Nasu, Y.
    Kumon, H.
    Okada, H.
    CANCER GENE THERAPY, 2016, 23 (08) : 278 - 283
  • [22] Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer
    H Sawahara
    H Shiraha
    D Uchida
    H Kato
    T Nagahara
    M Iwamuro
    J Kataoka
    S Horiguchi
    M Watanabe
    M Sakaguchi
    A Takaki
    K Nouso
    Y Nasu
    H Kumon
    H Okada
    Cancer Gene Therapy, 2016, 23 : 278 - 283
  • [23] ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody
    Sharma, Sai Kiran
    Mack, Kyeara N.
    Piersigilli, Alessandra
    Pourat, Jacob
    Edwards, Kimberly J.
    Keinanen, Outi
    Jiao, Maria S.
    Zhao, Huiyong
    White, Brandy
    Brooks, Cory L.
    de Stanchina, Elisa
    Madiyalakan, Madi R.
    Hollingsworth, Michael A.
    Radhakrishnan, Prakash
    Lewis, Jason S.
    Zeglis, Brian M.
    CLINICAL CANCER RESEARCH, 2022, 28 (05) : 948 - 959
  • [24] ROSIGLITAZONE: A POTENTIAL NEW STROMA TARGETED THERAPEUTIC AGENT IN COLON CANCER
    Tabuso, Maria
    Adya, Raghu
    Christian, Mark
    Arasaradnam, Ramesh P.
    GUT, 2019, 68 : A199 - A199
  • [25] Mastl, a Novel Therapeutic Target for Pancreatic Cancer Progression
    Fatima, I.
    Barman, S.
    Chauhan, S.
    Uppada, J. P.
    Talmon, G.
    Singh, A. B.
    Batra, S. K.
    Dhawan, P.
    PANCREAS, 2019, 48 (10) : 1426 - 1427
  • [26] Angiogenic switch: novel therapeutic target for pancreatic cancer
    Stump, Courtney A.
    Shah, Sapana
    Bonkovsky, Herbert L.
    Ghosh, Sriparna
    CANCER RESEARCH, 2012, 72
  • [27] Advanced stage pancreatic cancer: novel therapeutic options
    Saif, Muhammad Wasif
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (04) : 487 - 498
  • [28] Targeting FAK in pancreatic cancer: a novel therapeutic approach
    Stokes, Jayme
    Adair, Sara
    Slack-Davis, Jill
    Hershey, E.
    Tilghman, Robert
    Parsons, J.
    Bauer, Todd
    CANCER RESEARCH, 2009, 69
  • [29] A novel platform for identifying therapeutic index in pancreatic cancer
    Pantazopoulou, Vasiliki
    Engle, Dannielle
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Drug repurposing: A novel therapeutic approach for pancreatic cancer
    Gaikwad, Shreyas
    Srivastava, Sanjay K.
    FASEB JOURNAL, 2022, 36
12345